chartexchange

CARM
CARISMA THERAPEUTICS INC
stockOTC

EODNov 18, 2026
0.0002USD-33.333%(-0.0001)1,821
Loading…
Loading…
Healthcare
Biotechnology
HQ
Philadelphia, PA, USA
Previous Close
$0.00
Beta
-161.80
52-Week High
$0.10 2025-12-10
52-Week Low
$0.00 2026-06-08
SMA 50
$0.00
SMA 200
$0.01
Avg. Vol 10D
4,277
Avg. Vol 30D
56,245
Avg. Vol 90D
26,333
Relative Vol
0.03
30.14M
CARM Profile

eleven biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease. eleven biotherapeutics' scientists are engineering protein-based drugs using newly available structural information and the company's unique molecular understanding of clinical effects to create the next generation of protein-based medicines to treat important diseases with unmet needs, such as inflammatory conditions and coagulation disorders.

CARM Performance
PeriodPriceDateChangeBeta
1W0.002026-11-12-50.00%-31.208
3M0.002026-08-19-90.91%-70.544
6M0.002026-05-19+100.00%-273.304
1Y0.052025-11-19-99.61%-161.802
2Y0.872024-11-19-99.98%—
5Y3.612023-03-09-99.99%-36.786
CARM Stock Summary

CARISMA THERAPEUTICS INC (OTC:CARM) stock price today is $0.00, and today's volume is 1,821. CARM is down 33.333% today. The 30 day average volume is 56,245. CARM market cap is $8,358 with 41.79M shares outstanding.